Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07630207 · ClinicalTrials.gov registry record

Vascular Function in Adults With Down Syndrome

A clinical trial, sponsored by University of Nevada, Las Vegas.

Recruiting
Registry status
24
Enrollment target

NCT07630207 is a clinical trial that is actively recruiting participants, run by University of Nevada, Las Vegas. The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07630207 is actively recruiting participants, sponsored by University of Nevada, Las Vegas.

RECRUITING
Registry status
24 participants
Enrollment target

Study Summary

Adults with Down syndrome (Ds) are often thought to have a lower risk of heart and blood vessel disease because they tend to have lower blood pressure and fewer heart attacks than people without Ds. However, recent research suggests that heart and blood vessel diseases, including stroke, are becoming a more common cause of death in adults with Ds as life expectancy increases. Despite these findings, studies examining heart and blood vessel health in adults with Ds have produced mixed results, making it difficult to determine their true risk and whether preventive strategies are needed. This study will investigate the health of blood vessels in adults with Ds and compare the results with those of adults without Ds. Healthy blood vessels are important because they help deliver blood and oxygen throughout the body. Changes in blood vessel function and stiffness can occur with aging and may increase the risk of heart disease, stroke, kidney disease, and memory problems. The study aims to determine whether adults with Ds experience changes in blood vessel health that may place them at increased cardiovascular risk. Specifically, the study will: (1) Examine how well blood vessels function in adults with Ds; (2) Measure the stiffness of arteries in adults with Ds; (3) Compare two methods used to assess blood vessel function to determine whether a simpler exercise-based test provides results similar to a commonly used standard test. The findings may improve understanding of cardiovascular risk in adults with Ds and help guide future strategies to promote healthy aging in this population.

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2026-04-09
Est. Completion 2026-12-31

Sponsor

University of Nevada, Las Vegas

52 total trials

What the Registry Record Tells You About NCT07630207

The ClinicalTrials.gov registry entry for NCT07630207 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nevada, Las Vegas, which has 52 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT07630207 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07630207 about?

NCT07630207 is a clinical study titled "Vascular Function in Adults With Down Syndrome". Adults with Down syndrome (Ds) are often thought to have a lower risk of heart and blood vessel disease because they tend to have lower blood pressure and fewer heart attacks than people without Ds. However, recent research suggests that heart and blood vessel diseases, including stroke, are becomin...

What is the current status of trial NCT07630207?

This trial is currently recruiting. The enrollment target is 24 participants. The study started on 2026-04-09. Estimated completion is 2026-12-31.

Who is sponsoring clinical trial NCT07630207?

This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.